Consonance Capital Management LP Buys Surrozen Inc, ARYA Sciences Acquisition Corp V, Olink Holding AB, Sells Protagonist Therapeutics Inc, SpringWorks Therapeutics Inc, Legend Biotech Corp

• New Purchases: SRZN, ARYE, OLK,
• Reduced Positions: SWTX, TNDM, GMED, CASI, SLN,
• Sold Out: PTGX, LEGN, VSTM, KROS, SRPT, AFMD, GMDA, CFMS, DCPH, NKTX, INFI, ACET, CHFW.U, SIOX, CLRB, CMAX, ARYD, BCTG, TKNO,

For the details of Consonance Capital Management LP's stock buys and sells, go to https://www.gurufocus.com/guru/consonance+capital+management+lp/current-portfolio/portfolio

1. Tandem Diabetes Care Inc (TNDM) - 487,327 shares, 31.84% of the total portfolio. Shares reduced by 50.23%
2. Globus Medical Inc (GMED) - 589,100 shares, 24.71% of the total portfolio. Shares reduced by 45.7%
3. United Therapeutics Corp (UTHR) - 157,838 shares, 15.95% of the total portfolio. Shares reduced by 0.79%
4. SpringWorks Therapeutics Inc (SWTX) - 305,994 shares, 10.63% of the total portfolio. Shares reduced by 74.49%
5. Surrozen Inc (SRZN) - 1,000,000 shares, 3.68% of the total portfolio. New Position

Consonance Capital Management LP initiated holding in Surrozen Inc. The purchase prices were between $6.98 and $12.03, with an estimated average price of $8.91. The stock is now traded at around $9.500000. The impact to a portfolio due to this purchase was 3.68%. The holding were 1,000,000 shares as of 2021-09-30.

Consonance Capital Management LP initiated holding in ARYA Sciences Acquisition Corp V. The purchase prices were between $9.8 and $10.08, with an estimated average price of $9.92. The stock is now traded at around $9.850000. The impact to a portfolio due to this purchase was 1.62%. The holding were 300,000 shares as of 2021-09-30.

Consonance Capital Management LP initiated holding in Olink Holding AB. The purchase prices were between $23.42 and $37.93, with an estimated average price of $31.5. The stock is now traded at around $25.430000. The impact to a portfolio due to this purchase was 1.53%. The holding were 115,425 shares as of 2021-09-30.

Consonance Capital Management LP sold out a holding in Protagonist Therapeutics Inc. The sale prices were between $12.95 and $49.69, with an estimated average price of $42.78.

Consonance Capital Management LP sold out a holding in Legend Biotech Corp. The sale prices were between $35.31 and $50.56, with an estimated average price of $41.56.

Consonance Capital Management LP sold out a holding in Verastem Inc. The sale prices were between $2.54 and $4.07, with an estimated average price of $3.07.

Consonance Capital Management LP sold out a holding in Keros Therapeutics Inc. The sale prices were between $29.27 and $43.71, with an estimated average price of $35.63.

Consonance Capital Management LP sold out a holding in Sarepta Therapeutics Inc. The sale prices were between $65.97 and $92.48, with an estimated average price of $77.05.

Consonance Capital Management LP sold out a holding in Affimed NV. The sale prices were between $5.54 and $7.51, with an estimated average price of $6.59.